loadpatents
name:-0.0068860054016113
name:-0.0085809230804443
name:-0.0035960674285889
WATTERSON; Daniel Martin Patent Filings

WATTERSON; Daniel Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for WATTERSON; Daniel Martin.The latest application filed is for "map kinase modulators and uses thereof".

Company Profile
3.7.6
  • WATTERSON; Daniel Martin - Douglas MI
  • Watterson; Daniel Martin - Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Map Kinase Modulators And Uses Thereof
App 20220009905 - ARANCIO; Ottavio ;   et al.
2022-01-13
MAP kinase modulators and uses thereof
Grant 11,149,020 - Arancio , et al. October 19, 2
2021-10-19
Map Kinase Modulators And Uses Thereof
App 20190389840 - ARANCIO; Ottavio ;   et al.
2019-12-26
MAP kinase modulators and uses thereof
Grant 10,428,047 - Arancio , et al. October 1, 2
2019-10-01
Map Kinase Modulators And Uses Thereof
App 20170369472 - ARANCIO; Ottavio ;   et al.
2017-12-28
Map kinase modulators and uses thereof
Grant 9,783,525 - Arancio , et al. October 10, 2
2017-10-10
Map Kinase Modulators And Uses Thereof
App 20160130253 - ARANCIO; Ottavio ;   et al.
2016-05-12
Myosin light chain kinase inhibitor compounds, compositions and related methods of use
Grant 8,791,116 - Watterson , et al. July 29, 2
2014-07-29
Myosin Light Chain Kinase Inhibitor Compounds, Compositions And Related Methods Of Use
App 20130029999 - WATTERSON; DANIEL MARTIN ;   et al.
2013-01-31
Myosin light chain kinase inhibitor compounds, compositions and related methods of use
Grant 8,278,305 - Watterson , et al. October 2, 2
2012-10-02
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
Grant 8,088,774 - Watterson , et al. January 3, 2
2012-01-03
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
Grant 7,888,357 - Watterson , et al. February 15, 2
2011-02-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed